Vivera Pharmaceuticals, a United States-based pharmaceutical company, announced on Tuesday that it has named Donald D'Ambrosio as its new chief financial officer.
D'Ambrosio has more than four decades of experience serving in executive and officer roles within banking, investment, and finance companies. He also completed the acquisition and integration of Arcadian Telepsychiatry Services LLC and the reverse merger with Emmaus Life Sciences Inc. He funded and built Oxygen Funding Inc. He has held the position of senior vice president controller and CFO of BNC Mortgage Inc.
In the new role, D'Ambrosio is to direct and manage the firm's financial activities. He will also navigate transactions, handle risk, and work with external regulatory agencies related to capital raises to strengthen the company's long-term growth and financial performance.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer